Advisornet Financial’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,381
| Closed | -$2.93M | – | 1951 |
|
|
2021
Q2 | $2.93M | Buy |
11,381
+2,729
| +32% | +$702K | 0.19% | 118 |
|
|
2021
Q1 | $2.6M | Buy |
8,652
+44
| +0.5% | +$13.2K | 0.18% | 127 |
|
|
2020
Q4 | $2.2M | Buy |
8,608
+611
| +8% | +$156K | 0.18% | 122 |
|
|
2020
Q3 | $1.99M | Sell |
7,997
-1,358
| -15% | -$338K | 0.17% | 132 |
|
|
2020
Q2 | $3.25M | Sell |
9,355
-33
| -0.4% | -$11.5K | 0.26% | 88 |
|
|
2020
Q1 | $2.51M | Buy |
9,388
+149
| +2% | +$39.9K | 0.23% | 96 |
|
|
2019
Q4 | $2.99M | Buy |
9,239
+6,797
| +278% | +$2.2M | 0.25% | 90 |
|
|
2019
Q3 | $667K | Sell |
2,442
-2,992
| -55% | -$817K | 0.06% | 281 |
|
|
2019
Q2 | $2.9M | Buy |
5,434
+485
| +10% | +$259K | 0.32% | 71 |
|
|
2019
Q1 | $2.49M | Buy |
4,949
+845
| +21% | +$426K | 0.3% | 75 |
|
|
2018
Q4 | $2.02M | Sell |
4,104
-203
| -5% | -$100K | 0.28% | 85 |
|
|
2018
Q3 | $3.94M | Buy |
4,307
+2,707
| +169% | +$2.48M | 0.5% | 36 |
|
|
2018
Q2 | $1.17M | Sell |
1,600
-216
| -12% | -$158K | 0.16% | 127 |
|
|
2018
Q1 | $2.89M | Buy |
1,816
+1,507
| +488% | +$2.4M | 0.4% | 48 |
|
|
2017
Q4 | $277K | Buy |
+309
| New | +$277K | 0.04% | 300 |
|